Taro Pharmaceutical Industries (FRA:TAL) Total Payout Ratio : 0.00 (As of May. 17, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Taro Pharmaceutical Industries Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Taro Pharmaceutical Industries's current Total Payout Ratio is 0.00.

Taro Pharmaceutical Industries Total Payout Ratio Historical Data

The historical data trend for Taro Pharmaceutical Industries's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Total Payout Ratio Chart

Taro Pharmaceutical Industries Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Payout Ratio

Get a 7-Day Free Trial

2.09

0.11

-0.06

0.43

Taro Pharmaceutical Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Taro Pharmaceutical Industries's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taro Pharmaceutical Industries's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's Total Payout Ratio falls into.

Taro Pharmaceutical Industries Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Taro Pharmaceutical Industries's Total Payout Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	23.766
	=	0.00

Taro Pharmaceutical Industries's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	18.531
	=	0.00

Taro Pharmaceutical Industries Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Taro Pharmaceutical Industries (FRA:TAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (FRA:TAL) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

TARO:USA

Address

14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761

Website

https://www.taro.com

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.